Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia

被引:191
作者
Edison, Paul [1 ]
Ahmed, Imtiaz [1 ]
Fan, Zhen [1 ]
Hinz, Rainer [1 ,2 ]
Gelosa, Giorgio [1 ,3 ]
Chaudhuri, K. Ray [4 ]
Walker, Zuzana [5 ]
Turkheimer, Federico E. [1 ,4 ]
Brooks, David J. [1 ,6 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Neurosci, London W12 0NN, England
[2] Univ Manchester, Wolfson Mol Imaging Ctr, Manchester, Lancs, England
[3] Univ Milano Bicocca, Dept Neurol, Milan, Italy
[4] Kings Coll London, MRC Ctr Neurodegenerat Res, London WC2R 2LS, England
[5] UCL, Dept Mental Hlth, London, England
[6] GE Healthcare, Hammersmith Imanet, London, England
基金
英国医学研究理事会;
关键词
amyloid; microglia; Parkinson's disease; Parkinson's disease dementia; glucose metabolism; ALZHEIMERS-DISEASE; LEWY BODIES; IN-VIVO; BINDING; PET; BRAIN; INFLAMMATION; COGNITION;
D O I
10.1038/npp.2012.255
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
[C-11](R)PK11195-PET measures upregulation of translocator protein, which is associated with microglial activation, [C-11]PIB-PET is a marker of amyloid, while [F-18]FDG-PET measures cerebral glucose metabolism (rCMRGlc). We hypothesize that microglial activation is an early event in the Parkinson's disease (PD) spectrum and is independent of the amyloid pathology. The aim of this study is to evaluate in vivo the relationship between microglial activation, amyloid deposition, and glucose metabolism in Parkinson's disease dementia (PDD) and PD subjects without dementia. Here, we evaluated 11 PDD subjects, 8 PD subjects without dementia, and 24 control subjects. Subjects underwent T1 and T2 MRI, [C-11](R)PK11195, [F-18]FDG, and [C-11]PIB PET scans. Parametric maps of [C-11](R)PK11195 binding potential, rCMRGlc, and [C-11]PIB uptake were interrogated using region of interest and SPM (statistical parametric mapping) analysis. The PDD patients showed a significant increase of microglial activation in anterior and posterior cingulate, striatum, frontal, temporal, parietal, and occipital cortical regions compared with the controls. The PD subjects also showed a statistically significant increase in microglial activation in temporal, parietal, and occipital regions. [C-11]PIB uptake was marginally increased in PDD and PD. There was a significant reduction in glucose metabolism in PDD and PD. We have also demonstrated pixel-by-pixel correlation between mini-mental state examination (MMSE) score and microglial activation, and MMSE score and rCMRGlc. In conclusion, we have demonstrated that cortical microglial activation and reduced glucose metabolism can be detected early on in this disease spectrum. Significant microglial activation may be a factor in driving the disease process in PDD. Given this, agents that affect microglial activation could have an influence on disease progression. Neuropsychopharmacology (2013) 38, 938-949; doi:10.1038/npp.2012.255; published online 16 January 2013
引用
收藏
页码:938 / 949
页数:12
相关论文
共 46 条
[1]   A systematic comparison of kinetic modelling methods generating parametric maps for [11C]-(R)-PK11195 [J].
Anderson, Alexander N. ;
Pavese, Nicola ;
Edison, Paul ;
Tai, Yan F. ;
Hammers, Alexander ;
Gerhard, Alexander ;
Brooks, David J. ;
Turkheimer, Federico E. .
NEUROIMAGE, 2007, 36 (01) :28-37
[2]   The peripheral benzodiazepine binding site in the brain in multiple sclerosis -: Quantitative in vivo imaging of microglia as a measure of disease activity [J].
Banati, RB ;
Newcombe, J ;
Gunn, RN ;
Cagnin, A ;
Turkheimer, F ;
Heppner, F ;
Price, G ;
Wegner, F ;
Giovannoni, G ;
Miller, DH ;
Perkin, GD ;
Smith, T ;
Hewson, AK ;
Bydder, G ;
Kreutzberg, GW ;
Jones, T ;
Cuzner, ML ;
Myers, R .
BRAIN, 2000, 123 :2321-2337
[3]   Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG-PET [J].
Berding, G ;
Odin, P ;
Brooks, DJ ;
Nikkhah, G ;
Matthies, C ;
Peschel, T ;
Shing, M ;
Kolbe, H ;
van den Hoff, J ;
Fricke, H ;
Dengler, R ;
Samii, M ;
Knapp, WH .
MOVEMENT DISORDERS, 2001, 16 (06) :1014-1022
[4]  
Borghammer P, 2010, BRAIN STRUCT FUNCT, V214, P303, DOI 10.1007/s00429-010-0246-0
[5]   Subcortical elevation of metabolism in Parkinson's disease - A critical reappraisal in the context of global mean normalization [J].
Borghammer, Per ;
Cumming, Paul ;
Aanerud, Joel ;
Foerster, Stefan ;
Gjedde, Albert .
NEUROIMAGE, 2009, 47 (04) :1514-1521
[6]  
Brix G, 1997, J NUCL MED, V38, P1614
[7]  
Cummings J L, 1988, J Geriatr Psychiatry Neurol, V1, P24, DOI 10.1177/089198878800100106
[8]  
Cunningham VJ, 1993, J CEREB BLOOD FLOW M, V23, P13
[9]   CORTICAL GLUCOSE-METABOLISM IN PARKINSONS-DISEASE WITHOUT DEMENTIA [J].
EBERLING, JL ;
RICHARDSON, BC ;
REED, BR ;
WOLFE, N ;
JAGUST, WJ .
NEUROBIOLOGY OF AGING, 1994, 15 (03) :329-335
[10]   Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography [J].
Edison, P. ;
Rowe, C. C. ;
Rinne, J. O. ;
Ng, S. ;
Ahmed, I. ;
Kemppainen, N. ;
Villemagne, V. L. ;
O'Keefe, G. ;
Nagren, K. ;
Chaudhury, K. R. ;
Masters, C. L. ;
Brooks, D. J. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (12) :1331-1338